Bharat Biotech Launches Covid Nasal Vaccines As A Booster Dose For Adults | English News
December 25, 2022
256
3
1.17%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Mirror Now Episodes Around December 25, 2022
See what was published immediately before and after this episode.
3:05Now PlayingBharat Biotech Launches Covid Nasal Vaccines As A Booster Dose For Adults | English News
YouTube Description
as posted by the channelThe government today approved the inclusion of an intranasal Covid vaccine as a booster dose for adults in the vaccination programme. The addition comes amid an increase in cases in China and other countries. iNCOVACC, a two-drop nasal vaccine made in India, will be introduced on the Co-WIN platform. For the time being, Bharat Biotech's vaccine will only be available in private clinics. Those who have previously taken Covishield or Covaxin can use the nasal vaccine as a heterologous booster dose. In heterologous boosting, a different vaccine than the one used in the primary dose series is administered. In November, the Drugs Controller General of India approved the needle-free vaccine for limited use in an emergency situation.
#vaccineinindia #covidnasalvaccine #bharatbiotech
SUBSCRIBE NOW |
For More Updates ►
Like us on Facebook ►
Follow us on Twitter ►
Follow us on Instagram ►
Subscribe to our other network channels:
Times Now Navbharat
Pushed via Slike
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.